366 related articles for article (PubMed ID: 27744394)
1. Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
Faurschou M; Ahlström MG; Lindhardsen J; Obel N; Baslund B
J Rheumatol; 2017 Jan; 44(1):78-83. PubMed ID: 27744394
[TBL] [Abstract][Full Text] [Related]
2. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
[TBL] [Abstract][Full Text] [Related]
3. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
[TBL] [Abstract][Full Text] [Related]
4. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.
Petri H; Nevitt A; Sarsour K; Napalkov P; Collinson N
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):390-5. PubMed ID: 25132663
[TBL] [Abstract][Full Text] [Related]
5. Impact of pre-existing co-morbidities on mortality in granulomatosis with polyangiitis: a cohort study.
Faurschou M; Ahlström MG; Lindhardsen J; Baslund B; Obel N
Rheumatology (Oxford); 2016 Apr; 55(4):649-53. PubMed ID: 26615030
[TBL] [Abstract][Full Text] [Related]
6. All-cause and cause-specific mortality in patients with giant cell arteritis: a nationwide, population-based cohort study.
Therkildsen P; Nielsen BD; de Thurah A; Hansen IT; Nørgaard M; Hauge EM
Rheumatology (Oxford); 2022 Mar; 61(3):1195-1203. PubMed ID: 34164660
[TBL] [Abstract][Full Text] [Related]
7. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
8. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.
Ungprasert P; Upala S; Sanguankeo A; Warrington KJ
Mod Rheumatol; 2016; 26(3):410-4. PubMed ID: 26381748
[TBL] [Abstract][Full Text] [Related]
9. Pronounced Risk of Fractures among Elderly Men Affected by Granulomatosis with Polyangiitis.
Faurschou M; Baslund B; Obel N
J Rheumatol; 2015 Sep; 42(9):1667-71. PubMed ID: 26233512
[TBL] [Abstract][Full Text] [Related]
10. A cohort study of comorbidity in patients with granulomatosis with polyangiitis.
Li L; Neogi T; Jick S
Rheumatology (Oxford); 2018 Feb; 57(2):291-299. PubMed ID: 29069513
[TBL] [Abstract][Full Text] [Related]
11. A case of polyangiitis overlap syndrome of giant cell arteritis and granulomatosis with polyangiitis successfully treated with rituximab.
Shibata A; Kondo T; Kurasawa T; Chino K; Okada Y; Amano K
Mod Rheumatol Case Rep; 2021 Jul; 5(2):317-321. PubMed ID: 33250006
[TBL] [Abstract][Full Text] [Related]
12. Effect of diabetes mellitus on giant cell arteritis.
Abel AS; Yashkin AP; Sloan FA; Lee MS
J Neuroophthalmol; 2015 Jun; 35(2):134-8. PubMed ID: 25602744
[TBL] [Abstract][Full Text] [Related]
13. High risk of pulmonary embolism and deep venous thrombosis but not of stroke in granulomatosis with polyangiitis (Wegener's).
Faurschou M; Obel N; Baslund B
Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1910-4. PubMed ID: 25073637
[TBL] [Abstract][Full Text] [Related]
14. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany.
Herlyn K; Buckert F; Gross WL; Reinhold-Keller E
Rheumatology (Oxford); 2014 May; 53(5):882-9. PubMed ID: 24425780
[TBL] [Abstract][Full Text] [Related]
15. Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
Faurschou M; Mellemkjaer L; Voss A; Keller KK; Hansen IT; Baslund B
Rheumatology (Oxford); 2015 Aug; 54(8):1345-50. PubMed ID: 25234661
[TBL] [Abstract][Full Text] [Related]
16. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Proven A; Gabriel SE; Orces C; O'Fallon WM; Hunder GG
Arthritis Rheum; 2003 Oct; 49(5):703-8. PubMed ID: 14558057
[TBL] [Abstract][Full Text] [Related]
18. Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study.
Elfishawi M; Rakholiya J; Gunderson TM; Achenbach SJ; Crowson CS; Matteson EL; Turesson C; Wadström K; Weyand C; Koster MJ; Warrington KJ
J Rheumatol; 2023 Apr; 50(4):526-531. PubMed ID: 36521923
[TBL] [Abstract][Full Text] [Related]
19. Long-term risk and outcome of infection-related hospitalization in granulomatosis with polyangiitis: a nationwide population-based cohort study.
Faurschou M; Obel N; Baslund B
Scand J Rheumatol; 2018 Nov; 47(6):475-480. PubMed ID: 29741122
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies.
Romero-Gómez C; Aguilar-García JA; García-de-Lucas MD; Cotos-Canca R; Olalla-Sierra J; García-Alegría JJ; Hernández-Rodríguez J
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-11-8. PubMed ID: 25437862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
